Phyllis Foxworth, BSc

  • 3Articles
  • 47.5KReads1
  • 2022–2023Active
  • 18Collaborators
  • 156Citations2

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

About

Phyllis Foxworth, BSc, is affiliated with the Depression and Bipolar Support Alliance in Chicago, Illinois. She has published research on the clinical impact of treating major depressive disorder and its associated comorbidities, as well as the economic burden of medication costs for individuals with bipolar disorder. Her work, appearing between 2022 and 2023, often involves collaboration with co-authors such as Alix M. Arnaud and Brian Werneburg.

Publications

PCC
Impact of Treating Depression on Associated Comorbidities
Systematic Review

Impact of Treating Depression on Associated Comorbidities

January 3, 2023

Effective treatment of MDD may lead to a reduction in the severity of certain serious comorbidities. This review highlights the importance of appropriate and timely treatment of MDD.
, , , et al
JCP
Impact of Major Depressive Disorder on Comorbidities
Systematic Review

Impact of Major Depressive Disorder on Comorbidities

October 19, 2022

Associations between major depressive disorder (MDD) and comorbid disorders have been studied, but not all have been explored systematically. This study summarized observational data on the effect of MDD...
, , , et al
JCP
HSA-HDHPs and Bipolar Disorder Medication Cost Burden
Original Research

HSA-HDHPs and Bipolar Disorder Medication Cost Burden

March 9, 2022

This study examined the effects of high-deductible health plans paired with health savings accounts (HSA-HDHPs)—which require substantial out-of-pocket spending for most services—on medication out-of-pocket spending in people with bipolar...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe